Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hematoma Block vs. Bier Block for Closed Fracture Reduction
NCT05086224Phase 1Active, not recruiting
- Sponsor
- University of Utah
- Start
- Jul 2021
- Primary completion
- Jul 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Lidocaine Hydrochloride Injection, without epinephrine in distal radius fracture (2 arms), sponsored by University of Utah. Primary endpoint: Visual Analog Scale pain. Started Jul 2021; status: active, not recruiting.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
distal radius fracture
Beyond the preview
Go deeper on NCT05086224.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05086224.